Skip to content
Home/Companies/MedTech/CytaCoat

CytaCoat

MedTech·Sweden·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns CytaCoat?

CytaCoat is currently owned by Segulah Medical Acceleration through Segulah Medical Acceleration (2021 vintage), since 2021.

Hand-verified · updated 2026-08-17

Segulah Medical Acceleration
Investor
Segulah Medical Acceleration
Segulah Medical Acceleration · 2021 · Life Sciences VC

Key facts

HQSweden
SectorMedTech
StatusActive

More from Segulah Medical Acceleration

Other portfolio companies in the same fund.

Basic Genomics
Active
BiotechSweden· 2025
Protembis
Protembis
Active
MedTechGermany· 2024
Collective Minds Radiology
Active
HealthTechSweden· 2023
Senzime
Active
MedTechSweden· 2023
Navinci Diagnostics
Active
BiotechSweden· 2022
Quanta Dialysis Technologies
Quanta Dialysis Technologies
Active
MedTechUK· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track CytaCoat

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy CytaCoat?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on CytaCoat.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue